奥锐特，奥锐转债-

Summary of Conference Call Company and Industry - The document discusses the convertible bond issuance by Aorite Company, which is part of the pharmaceutical industry [1]. Core Points and Arguments - Aorite Company has successfully completed its convertible bond issuance with a total scale of 8.12 billion [1]. - This issuance is categorized as medium to large within the pharmaceutical industry's convertible bonds [1]. - The shareholder subscription rate exceeded 85%, indicating high market interest and recognition [1]. Other Important Content - The presence of the company’s representative, Mr. Li, suggests a focus on investor relations and communication [1].